Software tool enabling scientists to create and share professional, standardized scientific figures in minutes.
Scientists lack affordable, accessible tools to create professional scientific figures and illustrations, forcing them to either hire expensive illustrators or spend valuable research time learning complex design software.
Scientists lack affordable, accessible tools to create professional scientific figures and illustrations, forcing them to either hire expensive illustrators or spend valuable research time learning complex design software.
Drag-and-drop software platform with 50,000+ curated icons and templates across 30+ life science fields, enabling researchers to create publication-ready scientific figures in minutes.
Drag-and-drop software platform with 50,000+ curated icons and templates across 30+ life science fields, enabling researchers to create publication-ready scientific figures in minutes.
Appears active as of February 2026 based on current website and careers page.
Appears active as of February 2026 based on current website and careers page.
BioRender is a venture-backed software platform designed to empower scientists and researchers to create professional scientific figures and illustrations without requiring specialized design skills. Founded in 2017 by Shiz Aoki, Katya Shteyn, and Ryan Marien, the company addresses a critical gap in scientific communication by providing an intuitive, drag-and-drop interface that simplifies the process of generating publication-ready visuals.
Scientists and researchers traditionally face significant challenges when attempting to communicate their work visually. Creating professional scientific illustrations typically requires hiring specialized medical illustrators or possessing advanced design skills, both of which are time-consuming and costly. Many researchers lack access to affordable illustration services, forcing them to either create substandard visuals or allocate precious research time to learning complex design software. This bottleneck in scientific communication slows down the dissemination of research findings and limits the clarity with which discoveries can be shared with peers, funding bodies, and the broader scientific community.
BioRender is a venture-backed software platform designed to empower scientists and researchers to create professional scientific figures and illustrations without requiring specialized design skills. Founded in 2017 by Shiz Aoki, Katya Shteyn, and Ryan Marien, the company addresses a critical gap in scientific communication by providing an intuitive, drag-and-drop interface that simplifies the process of generating publication-ready visuals.
Scientists and researchers traditionally face significant challenges when attempting to communicate their work visually. Creating professional scientific illustrations typically requires hiring specialized medical illustrators or possessing advanced design skills, both of which are time-consuming and costly. Many researchers lack access to affordable illustration services, forcing them to either create substandard visuals or allocate precious research time to learning complex design software. This bottleneck in scientific communication slows down the dissemination of research findings and limits the clarity with which discoveries can be shared with peers, funding bodies, and the broader scientific community.
Subscription-based SaaS with individual and institutional licensing options.
Subscription-based SaaS with individual and institutional licensing options.
Scientists, researchers, and institutions at universities, pharmaceutical companies, and scientific journals.
Scientists, researchers, and institutions at universities, pharmaceutical companies, and scientific journals.
Active careers page and website as of February 2026; company describes itself as profitable and growth-stage.
Hiring: Active careers page with open positions and detailed interview process description.
Active careers page and website as of February 2026; company describes itself as profitable and growth-stage.
Hiring: Active careers page with open positions and detailed interview process description.
BioRender provides a comprehensive platform that democratizes scientific figure creation. The software features an extensive library of over 50,000 curated icons and templates spanning more than 30 life science fields, including biology, biochemistry, cell biology, genetics, and many others. Users can leverage these pre-built components through a simple drag-and-drop interface to construct complex scientific diagrams in minutes rather than hours or days. The platform also allows researchers to upload their own images and apply consistent BioRender styling, ensuring visual coherence across figures. Advanced features include AI-powered first drafts for protocols, timelines, and flowcharts that users can refine and customize to match their specific needs.
BioRender provides a comprehensive platform that democratizes scientific figure creation. The software features an extensive library of over 50,000 curated icons and templates spanning more than 30 life science fields, including biology, biochemistry, cell biology, genetics, and many others. Users can leverage these pre-built components through a simple drag-and-drop interface to construct complex scientific diagrams in minutes rather than hours or days. The platform also allows researchers to upload their own images and apply consistent BioRender styling, ensuring visual coherence across figures. Advanced features include AI-powered first drafts for protocols, timelines, and flowcharts that users can refine and customize to match their specific needs.
The platform accelerates figure creation by up to 50 times compared to traditional methods, according to the company. Users benefit from standardized visual language that enhances clarity and professionalism across scientific communications. The software supports collaboration, allowing multiple researchers to work on figures simultaneously. BioRender maintains a remote-first operational model, enabling team members and users to work flexibly across the United States and Canada. The platform has been adopted by researchers at leading universities, pharmaceutical companies, and scientific journals worldwide.
The platform accelerates figure creation by up to 50 times compared to traditional methods, according to the company. Users benefit from standardized visual language that enhances clarity and professionalism across scientific communications. The software supports collaboration, allowing multiple researchers to work on figures simultaneously. BioRender maintains a remote-first operational model, enabling team members and users to work flexibly across the United States and Canada. The platform has been adopted by researchers at leading universities, pharmaceutical companies, and scientific journals worldwide.
BioRender operates as a venture-backed startup and Y Combinator graduate, positioning it within a network of high-growth technology companies. The platform serves users across more than 100 countries globally. The company has built substantial institutional credibility, with adoption among top-tier research institutions and major pharmaceutical organizations. This widespread adoption reflects both the utility of the platform and the universal nature of the scientific communication challenge it addresses.
BioRender operates as a venture-backed startup and Y Combinator graduate, positioning it within a network of high-growth technology companies. The platform serves users across more than 100 countries globally. The company has built substantial institutional credibility, with adoption among top-tier research institutions and major pharmaceutical organizations. This widespread adoption reflects both the utility of the platform and the universal nature of the scientific communication challenge it addresses.
The company operates on a subscription-based software-as-a-service (SaaS) model, generating recurring revenue from individual researchers, institutional licenses, and enterprise customers. BioRender has achieved profitability while maintaining a growth trajectory comparable to high-performing SaaS companies. The company is backed by top-tier investors and maintains a venture-backed status, indicating continued access to capital for product development and market expansion.
The company operates on a subscription-based software-as-a-service (SaaS) model, generating recurring revenue from individual researchers, institutional licenses, and enterprise customers. BioRender has achieved profitability while maintaining a growth trajectory comparable to high-performing SaaS companies. The company is backed by top-tier investors and maintains a venture-backed status, indicating continued access to capital for product development and market expansion.
BioRender's mission centers on accelerating the world's ability to learn, discover, and communicate science. The company is driven by the vision of empowering scientists to quickly and consistently create their own professional medical illustrations, removing barriers to effective scientific communication. As artificial intelligence reshapes biology research and the pace of discovery accelerates, BioRender positions itself as essential infrastructure for translating complex scientific findings into clear, trustworthy visuals that advance understanding across the research community.
BioRender's mission centers on accelerating the world's ability to learn, discover, and communicate science. The company is driven by the vision of empowering scientists to quickly and consistently create their own professional medical illustrations, removing barriers to effective scientific communication. As artificial intelligence reshapes biology research and the pace of discovery accelerates, BioRender positions itself as essential infrastructure for translating complex scientific findings into clear, trustworthy visuals that advance understanding across the research community.
